Lead Biomarker Statistician (Genomics/Oncology)

1001 Syneos Health, LLC; France; Hybride; EUR 106 000 - 151 000; Plein temps

Résumé du poste

Syneos Health seeks a Principal Biostatistician (Biomarker Analyst) for global biomarker statistics across EMEA and the US. Lead analyses, design SAPs, and oversee statistical deliverables in collaboration with cross-functional teams.

The role requires a biostatistics graduate degree, extensive trial experience, SAS proficiency, and strong communication. Mentors staff and supports regulatory submissions, while aiding project timelines and quality.

Qualifications

• Graduate degree in biostatistics or related discipline.
• Extensive experience in clinical trials with ability to lead multiple projects.
• Proficiency in programming and statistical design.
• Experience with biomarker evaluation, oncology and ctDNA data.

Responsabilités

• Collaborates with cross-functional teams to plan, analyze and manage biomarker aspects of studies.
• Develops the Biomarker Evaluation Plan and ensures consistency across projects.
• Conducts advanced data analysis for genomics and biomarker statistics, including programming.
• Produces Biomarker Evaluation Reports and interprets statistical deliverables.
• Mentors biostatisticians and contributes to training and SOPs.
• Supports SAP preparation, CSR deliverables, and regulatory interactions as needed.

Connaissances

Biomarker evaluation

Programming

Communication skills

Regulatory submissions

Formation

Graduate degree in biostatistics or related discipline

Outils

SAS

Description du poste

Syneos Health seeks a Principal Biostatistician (Biomarker Analyst) for global biomarker statistics across EMEA and the US. Lead analyses, design SAPs, and oversee statistical deliverables in collaboration with cross-functional teams.

The role requires a biostatistics graduate degree, extensive trial experience, SAS proficiency, and strong communication. Mentors staff and supports regulatory submissions, while aiding project timelines and quality.